MedPath

Conceptual study on Covid 19 as per Ayurveda and role Of Ayush 64 in its managment.

Not Applicable
Conditions
Health Condition 1: J989- Respiratory disorder, unspecified
Registration Number
CTRI/2022/05/042520
Lead Sponsor
All India Istitute Of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients who have recovered from Covid 19 with RT-PCR negative.

2.Patients who are suffered from Covid 19 complications with test report RT-PCR

negative.

3.Patients who have taken AYUSH 64 minimum 7 days with or without any other Ayurvedic medicine for the management of Covid 19.

4.Patients Age group 18 to 60 years.

Exclusion Criteria

1.Patients suffering from any psychosomatic conditions.]

2. The patients who have volunteered to discontinue the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath